Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-07 Purchase | 2023-08-09 4:10 pm | Vistagen Therapeutics Inc. | VTGN | COMMODORE CAPITAL LP 10% Owner | 775,756 | $23.15 | $17,961,079 | 1,575,000 (Indirect) | View |
| 2022-08-18 Purchase | 2022-08-22 5:12 pm | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 200,000 | $0.1787 | $35,740 | 400,000 (Indirect Direct) | View |
| 2022-08-17 Purchase | 2022-08-19 3:45 pm | VistaGen Therapeutics Inc. | VTGN | Adler Reid G. CHIEF LEGAL OFFICER | 300,000 | $0.1697 | $50,910 | 334,629 (Direct) | View |
| 2022-08-17 Purchase | 2022-08-18 3:56 pm | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 600,000 | $0.172 | $103,200 | 780,232 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-31 Option Award | 2025-01-13 5:40 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Prince Joshua S. Chief Operating Officer | 3,310 | $2.5075 | 5,981 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-13 5:39 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER | 2,592 | $2.5075 | 6,184 (Direct) | View |
| 2024-09-06 Option Award | 2024-09-10 5:00 pm | N/A 2034-09-06 | Vistagen Therapeutics Inc. | VTGN | SAXE JON S Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2024-09-06 Option Award | 2024-09-10 5:00 pm | N/A 2034-09-06 | Vistagen Therapeutics Inc. | VTGN | GIN JERRY B Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2024-09-06 Option Award | 2024-09-10 5:00 pm | N/A 2034-09-06 | Vistagen Therapeutics Inc. | VTGN | Curley Joanne Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2024-09-06 Option Award | 2024-09-10 5:00 pm | N/A 2034-09-06 | Vistagen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2024-09-06 Option Award | 2024-09-10 5:00 pm | N/A 2034-09-06 | Vistagen Therapeutics Inc. | VTGN | Rotunno Mary L. Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2024-09-06 Option Award | 2024-09-10 5:00 pm | N/A 2034-09-06 | Vistagen Therapeutics Inc. | VTGN | FitzPatrick Margaret M Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 6:10 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Prince Joshua S. Chief Operating Officer | 2,671 | $2.958 | 2,671 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 6:08 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER | 3,592 | $2.958 | 3,592 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 6:07 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS | 4,854 | $2.958 | 16,509 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 6:06 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 4,854 | $2.958 | 31,362 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:31 pm | N/A 2034-06-24 | Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 500,000 | $0 | 500,000 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Vistagen Therapeutics Inc. | VTGN | Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS | 170,000 | $0 | 170,000 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Vistagen Therapeutics Inc. | VTGN | Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:29 pm | N/A 2034-06-24 | Vistagen Therapeutics Inc. | VTGN | Prince Joshua S. Chief Operating Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 6:00 pm | N/A 2034-03-04 | Vistagen Therapeutics Inc. | VTGN | Rotunno Mary L. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 6:00 pm | N/A 2034-03-04 | Vistagen Therapeutics Inc. | VTGN | GIN JERRY B Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 6:00 pm | N/A 2034-03-04 | Vistagen Therapeutics Inc. | VTGN | FitzPatrick Margaret M Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 6:00 pm | N/A 2034-03-04 | Vistagen Therapeutics Inc. | VTGN | Curley Joanne Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 6:00 pm | N/A 2034-03-04 | Vistagen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 6:00 pm | N/A 2034-03-04 | Vistagen Therapeutics Inc. | VTGN | SAXE JON S Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 5:19 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS | 167 | $1.717 | 11,655 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 5:17 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 167 | $1.717 | 26,508 (Direct) | View |
Ownership | 2023-11-03 8:14 pm | N/A 2031-11-15 | Vistagen Therapeutics Inc. | VTGN | Prince Joshua S. Chief Operating Officer | 0 | $0 | 13,335 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-06 4:05 pm | 2023-10-04 N/A | Vistagen Therapeutics Inc. | VTGN | COMMODORE CAPITAL LP 10% Owner | 5,872,944 | $0 | 5,872,944 (Indirect) | View |
| 2023-08-21 Option Award | 2023-08-23 1:09 pm | N/A 2033-08-21 | Vistagen Therapeutics Inc. | VTGN | Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER | 8,333 | $0 | 8,333 (Direct) | View |
Ownership | 2023-08-09 4:05 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | COMMODORE CAPITAL LP 10% Owner | 0 | $0 | 799,244 (Indirect) | View |
| 2023-06-30 Option Award | 2023-07-05 4:05 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 167 | $1.5895 | 26,341 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 4:05 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Adler Reid G. CHIEF LEGAL OFFICER | 167 | $1.5895 | 11,488 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 4:05 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO | 167 | $1.5895 | 3,671 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-03 4:11 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | 5,000 | $0.0876 | 105,111 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-03 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 5,000 | $0.0876 | 785,232 (Direct) | View |
| 2022-07-30 Option Award | 2022-07-15 4:30 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | 5,000 | $0.748 | 100,111 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-15 4:30 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 5,000 | $0.748 | 180,232 (Direct) | View |